new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing
November 2000
Merck will soon market new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing.
The new tabs come in two strengths...35 and 70 mg.
The 35 mg tab is for patients taking 5 mg/day to PREVENT osteoporosis. The 70 mg tab is for those taking 10 mg/day for TREATMENT.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive